Die Brückenköpfe
VC Fund
Berlin, Germany
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Die Brückenköpfe invests in
Stages Die Brückenköpfe invests in
Countries Die Brückenköpfe invests in
Round sizes
Round size
- Seed
- $2M–$2.1M
- Series A
- $5.5M–$17M
Investment Focus
Industry
- Health Care 3 (43%)
- Life Science 2 (29%)
- Therapeutics 2 (29%)
- Personal Health 2 (29%)
- SaaS 1 (14%)
Stage
- Seed 3 (43%)
- Series A 2 (29%)
- Pre-Seed 1 (14%)
- Funding Round 1 (14%)
Country
- Germany 6 (86%)
- Austria 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Skinuvita
|
Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home. | $2M / Seed / Jul 15, 2024 | |
anvajo
|
Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof. | $17.3M / Series A / Oct 19, 2022 | |
Recare
|
Recare rethinks discharge management. Our digital solutions optimize the clinical pathways between hospitals and care providers. The centerpiece is our cloud-based platform. It enables real-time coordination of capacities and secure, privacy-compliant communication. This leaves more time for the really important things: patient care. | $2.1M / Seed / Jan 07, 2021 | |
keleya
|
Keleya enables women and their partners to have a safe and relaxed pregnancy, birth experience and motherhood by providing them with personalized, expert based information, workouts and nutrition plans and a matching midwife. Founded in 2017, Kelaya is headquartered in Berlin, Germany. | Seed / Oct 25, 2019 | |
Betterguards
|
Betterguards is a Berlin-Brandenburg-based start-up that changes the way avoid and treat acute injuries to joints or ligaments. Like a seatbelt the Betterguards Technology allows a high range of motion while joints are effectively protected from injury-causing movements. | May 15, 2019 | |
Medicus AI
|
Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools. | $5.5M / Series A / Feb 04, 2019 | |
RetroBrain R&D GmbH
|
Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany. | $329K / Pre-Seed / Jun 23, 2016 |
Co-Investors
HTGF (High-Tech Gruenderfonds)
2 deals together
MediVentures
2 deals together
Algorithm Ltd
1 deal together
Brandenburg Kapital
1 deal together
Biopart
1 deal together
Bremer Aufbau-Bank GmbH
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Die Brückenköpfe invest in?
Die Brückenköpfe invests primarily in Health Care, Life Science and Therapeutics startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Die Brückenköpfe's check size?
Die Brückenköpfe typically joins rounds of $2M–$2.1M at Seed and $5.5M–$17M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Die Brückenköpfe participates in.
When did Die Brückenköpfe last invest?
The most recent investment recorded for Die Brückenköpfe closed in Jul 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
